Home » Topics » Regulatory » Patents

Patents
RSS

Fujisawa reports heterocyclic glutamate receptor antagonists

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Neurogen describes dopamine receptor subtype-specific ligands

Nov. 11, 1997

New oxazolidinone antibiotics described by Zeneca

Nov. 11, 1997

New taxoids from RPR

Nov. 10, 1997

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Nov. 10, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Quinoxalinediones for neurodegenerative/neurological disorders patented

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Takeda describes new melatonin agonists

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...